Nathoe HM - Search Results

1

Annotation of loci from genome-wide association studies using tissue-specific quantitative interaction proteomics.

Lundby A, Rossin EJ, Steffensen AB, Acha MR, Newton-Cheh C, Pfeufer A, Lynch SN; QT Interval International GWAS Consortium (QT-IGC); Olesen SP, Brunak S, Ellinor PT, Jukema JW, Trompet S, Ford I, Macfarlane PW, Krijthe BP, Hofman A, Uitterlinden AG, Stricker BH, Nathoe HM, Spiering W, Daly MJ, Asselbergs FW, van der Harst P, Milan DJ, de Bakker PI, Lage K, Olsen JV. Lundby A, et al. Among authors: nathoe hm. Nat Methods. 2014 Aug;11(8):868-74. doi: 10.1038/nmeth.2997. Epub 2014 Jun 22. Nat Methods. 2014. PMID: 24952909 Free PMC article.

2

Coronary collaterals improve prognosis in patients with ischemic heart disease.

Regieli JJ, Jukema JW, Nathoe HM, Zwinderman AH, Ng S, Grobbee DE, van der Graaf Y, Doevendans PA. Regieli JJ, et al. Among authors: nathoe hm. Int J Cardiol. 2009 Feb 20;132(2):257-62. doi: 10.1016/j.ijcard.2007.11.100. Epub 2008 Feb 1. Int J Cardiol. 2009. PMID: 18242732

3

Measuring and targeting aldosterone and renin in atherosclerosis-a review of clinical data.

Hillaert MA, Lentjes EG, Beygui F, Kemperman H, Asselbergs FW, Nathoe HM, Agostoni P, Voskuil M, Ivanes F, Jude B, Bertrand ME, Pasterkamp G, van der Graaf Y, Doevendans PA, Montalescot G, Van Belle E. Hillaert MA, et al. Among authors: nathoe hm. Am Heart J. 2011 Oct;162(4):585-96. doi: 10.1016/j.ahj.2011.06.015. Epub 2011 Sep 9. Am Heart J. 2011. PMID: 21982648 Review.

4

Increased visceral adipose tissue is associated with increased resting heart rate in patients with manifest vascular disease.

Bemelmans RH, van der Graaf Y, Nathoe HM, Wassink AM, Vernooij JW, Spiering W, Visseren FL; SMART Study Group. Bemelmans RH, et al. Among authors: nathoe hm. Obesity (Silver Spring). 2012 Apr;20(4):834-41. doi: 10.1038/oby.2011.321. Epub 2011 Oct 20. Obesity (Silver Spring). 2012. PMID: 22016101 Free article.

5

Risk of elevated resting heart rate on the development of type 2 diabetes in patients with clinically manifest vascular diseases.

Bemelmans RH, Wassink AM, van der Graaf Y, Nathoe HM, Vernooij JW, Spiering W, Visseren FL; SMART Study Group. Bemelmans RH, et al. Among authors: nathoe hm. Eur J Endocrinol. 2012 Apr;166(4):717-25. doi: 10.1530/EJE-11-1017. Epub 2012 Jan 27. Eur J Endocrinol. 2012. PMID: 22285702

6

Hypertensive target organ damage and the risk for vascular events and all-cause mortality in patients with vascular disease.

Vernooij JW, van der Graaf Y, Nathoe HM, Bemelmans RH, Visseren FL, Spiering W. Vernooij JW, et al. Among authors: nathoe hm. J Hypertens. 2013 Mar;31(3):492-99; discussion 499-500. doi: 10.1097/HJH.0b013e32835cd3cd. J Hypertens. 2013. PMID: 23303394

7

The risk of resting heart rate on vascular events and mortality in vascular patients.

Bemelmans RH, van der Graaf Y, Nathoe HM, Wassink AM, Vernooij JW, Spiering W, Visseren FL; SMARTStudy Group. Bemelmans RH, et al. Among authors: nathoe hm. Int J Cardiol. 2013 Sep 30;168(2):1410-5. doi: 10.1016/j.ijcard.2012.12.043. Epub 2013 Jan 8. Int J Cardiol. 2013. PMID: 23305859

8

Toll-Like Receptor induced CD11b and L-selectin response in patients with coronary artery disease.

Elsenberg EH, Hillaert MA, den Ruijter HM, Sels JW, Scholtes VP, Nathoe HM, Kuiper J, Jukema JW, Doevendans PA, Pasterkamp G, Hoefer IE. Elsenberg EH, et al. Among authors: nathoe hm. PLoS One. 2013;8(4):e60467. doi: 10.1371/journal.pone.0060467. Epub 2013 Apr 3. PLoS One. 2013. PMID: 23573259 Free PMC article.

9

The impact of susceptibility loci for coronary artery disease on other vascular domains and recurrence risk.

Tragante V, Doevendans PA, Nathoe HM, van der Graaf Y, Spiering W, Algra A, de Borst GJ, de Bakker PI, Asselbergs FW; SMART study group. Tragante V, et al. Among authors: nathoe hm. Eur Heart J. 2013 Oct;34(37):2896-904. doi: 10.1093/eurheartj/eht222. Epub 2013 Jul 4. Eur Heart J. 2013. PMID: 23828831

10

The combined use of aspirin, a statin, and blood pressure-lowering agents (polypill components) and the risk of vascular morbidity and mortality in patients with coronary artery disease.

Lafeber M, Spiering W, van der Graaf Y, Nathoe H, Bots ML, Grobbee DE, Visseren FL. Lafeber M, et al. Am Heart J. 2013 Aug;166(2):282-289.e1. doi: 10.1016/j.ahj.2013.04.011. Epub 2013 Jun 15. Am Heart J. 2013. PMID: 23895811

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

153 results

Search Page